Genesense Technologies, Inc.

Canada

 
Total IP 2
Total IP Rank # 722,138
IP Activity Score 0/5.0    0
IP Activity Rank # 1,660,322

Patents

Trademarks

0 0
0 0
2 0
0
 
Last Patent 2006 - 2-indolyl imidazo⏧4,5-d]phe...
First Patent 1997 - Antitumor antisense sequences di...

Latest Inventions, Goods, Services

2006 Invention 2-indolyl imidazo⏧4,5-d]phenanthroline derivatives and their use in the treatment of cancer....
Invention Use of interleukin 17e for the treatment of cancer. The use of interleukin 17E to inhibit tumour ...
2005 Invention Combination preparation of a biological response modifier and an anticancer agent and uses thereo...
Invention Small interfering rna molecules against ribonucleotide reductase and uses thereof. Small interfer...
Invention Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combinatio...
2004 Invention Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatm...
Invention Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatm...
2000 Invention Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms....
Invention Antisense oligonucleotide sequences derived from groel and groes as inhibitors microorganisms. Th...
Invention Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase. ...
1999 Invention Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to mo...
Invention Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth....
Invention Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods...
1998 Invention Antisense oligonucleotide sequences as inhibitors of microorganisms. The invention relates to ant...
Invention Suppression of malignancy utilizing ribonucleotide reductase r1. The present invention provides a...